Sutro Biopharma Inc at JPMorgan Healthcare Conference Transcript
Hello, everyone. Welcome to JPMorgan Healthcare Conference. My name is Matt Bannon. I'm a health care banker here at JPM. I am really excited to be setting the stage for a next presenting company, Sutro Biopharma. And presenting on behalf of Sutro, we have CEO, Bill Newell.
Thank you, Matt, and thank you to JPMorgan for giving us the opportunity to help you all close out the conference this year. I'm Bill Newell, I'm the CEO of Sutro Biopharma. And as you might imagine, in my discussions today with you, we're going to make some forward-looking statements and our legal team appreciates it, if you would pay attention to this slide because it indicates things that you need to know about those forward-looking statements.
When I first came to Sutro in 2009, I was the 19th employee. We had a novel proprietary cell-free protein synthesis platform, it was unique and it was a long way away from being where we are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |